Search results (9)
« Back to NewsNew Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
7 December 2021
GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
Researchers identify genetic cause of endometriosis and potential drug target
31 August 2021
Endometriosis is a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus.
Eoghan Mulholland receives prestigious Lee Placito Research Fellowship
12 May 2021
Dr Eoghan Mulholland has received the prestigious Lee Placito Research Fellowship in Gastrointestinal Cancer. Eoghan will use this 3-year position to research cell interactions in colorectal cancers.
Ancient gene mutation found to cause rare hereditary condition
18 January 2021
UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).
Dr Ross Chapman welcomed as EMBO Young Investigator
20 November 2018
Wellcome Centre for Human Genetics researcher Dr Ross Chapman has been selected as one of the European Molecular Biology Organisation's Young Investigators for 2018.